2025 Update in Hematology and Medical Oncology


2025 Update in Hematology and Medical Oncology Banner

Add to Calendar 2025 Update in Hematology and Medical Oncology 3/7/2025 9:00:00 AM 3/10/2025 2:45:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=49921 Description: The 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology, condensed into an intensive three-and-a-half-day virtual program, provides a thorough and up-to-date review of the diagnosis, staging, and management of neoplastic diseases, encompassing both solid tumors and hematologic malignancies. Lectures and discussions focus on disease-specific topics in gastrointestinal, g... Online false MM/DD/YYYY


Date & Location
Friday, March 7, 2025, 9:00 AM - Monday, March 10, 2025, 2:45 PM, Online

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

The 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology, condensed into an intensive three-and-a-half-day virtual program, provides a thorough and up-to-date review of the diagnosis, staging, and management of neoplastic diseases, encompassing both solid tumors and hematologic malignancies. Lectures and discussions focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

This course is a live virtual event designed for medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. It aims to help participants effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

Participants will also receive access to an online syllabus featuring select PDFs of presentation slides and video recordings of the lectures.

Objectives
At the conclusion of this course, attendees will be able to:

  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
  3. Prepare for ABIM examinations in medical oncology and hematology.

Registration

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Fees

— Physicians (MDs, PhDs, and DOs): $2,000
— APPs, Residents, Fellows, Nurses, and Other Healthcare Providers: $1,075
— Industry Professionals: $3,500*
— MSK Employees: Complimentary

*An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

For details on our cancellation terms, please review our Cancellation Policy.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 34.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 34.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.